Abstract
A syringe for medical use having a barrel with a longitudinally extending tubular fluid chamber and at least one longitudinally extending, outwardly facing, substantially flat indicia display surface disposed proximally to the fluid chamber, a plunger slidably inserted into the fluid chamber, a needle projecting forwardly from the barrel in fluid communication with the fluid chamber; and a fixed length needle safety device having an activation handle slidably engaging the barrel and a forwardly projecting needle tip shield encircling the needle that moves forwardly to cover a tip end of the needle when the activation handle is moved forwardly following use of the syringe.
Claims
1. A syringe for medical use comprising: a barrel further comprising a longitudinally extending tubular fluid chamber, a nose disposed forwardly of the chamber, a rearwardly facing opening, and at least one longitudinally extending, outwardly facing, substantially flat indicia display surface disposed proximally to the fluid chamber; a plunger slidably inserted into the tubular fluid chamber through the rearwardly facing opening; a needle projecting forwardly from the nose in fluid communication with the fluid chamber; and a needle safety device slidably engaging the barrel.
2. The syringe of claim 1 wherein the barrel comprises two oppositely facing, substantially flat indicia display surfaces.
3. The syringe of claim 1 wherein a volumetric scale is applied to the indicia display surface.
4. The syringe of claim 2 wherein a volumetric scale is applied to each indicia display surface.
5. The syringe of claim 3 wherein the volumetric scale is applied to the indicia display surface by at least one of a group of application methods consisting of molding, stamping, embossing or printing.
6. The syringe of claim 4 wherein the volumetric scale is applied to the indicia display surface by at least one of a group of application methods consisting of molding, stamping, embossing or printing.
7. The syringe of claim 5 wherein the volumetric scale is applied to the indicia display surface by pad printing.
8. The syringe of claim 6 wherein the volumetric scale is applied to the indicia display surface by pad printing.
9. The syringe of claim 1 wherein the needle safety device has and maintains a fixed overall length and further comprises a forwardly facing needle tip shield circumferentially surrounding the needle and an activation handle disposed behind the needle tip shield.
10. The syringe of claim 9 wherein the activation handle slidably engages the barrel.
11. The syringe of claim 10 wherein the activation handle further comprises a touch surface.
12. The syringe of claim 10 wherein the barrel and the activation handle comprise cooperatively engageable elements that enable manually actuated and controllable, longitudinally slidable movement of the activation handle relative to the barrel between two predetermined stop positions.
13. The syringe of claim 12 wherein the first of the two predetermined stop positions is a fully retracted use position in which the needle tip shield substantially surrounds the nose.
14. The syringe of claim 12 wherein the second of the two predetermined stop positions is a fully extended post-use position in which the needle tip shield circumferentially surrounds a tip end of the forwardly projecting needle.
15. The syringe of claim 1 wherein the forwardly projecting needle is disposed in fixed relation to the nose of the barrel.
16. The syringe of claim 1 further comprising a needle cap.
17. The syringe of claim 1 further comprising a plunger cap.
18. The syringe of claim 1 wherein the plunger further comprises a plunger seal and a thumb cap.
19. The syringe of claim 17 wherein the barrel further comprises a rearwardly facing collar sized and configured to engage and support the plunger cap.
20. The syringe of claim 19 further comprising a transversely projecting finger flange disposed forwardly of the rearwardly facing collar.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0023] The syringe of the invention is further described and explained in relation to the following drawings wherein:
[0024] FIG. 1 is a top front perspective view of one embodiment of the invention in which the needle cover (including the locking member) and the plunger end cap are installed in the position in which the subject syringes can be packaged, shipped and stored, with the locking member of the needle cover restricting lateral sliding movement of the barrel relative to the frontal attachment prior to use;
[0025] FIG. 2 is a top front perspective view of the embodiment of FIG. 1 in which the needle cover is removed;
[0026] FIG. 3 is an exploded top front perspective view of the embodiment of FIG. 1;
[0027] FIG. 4 is a right side elevation view of the embodiment of FIG. 2;
[0028] FIG. 5 is a cross-sectional view taken along line 5-5 of FIG. 4;
[0029] FIG. 6 is an exploded detail perspective view, partially broken away, of the frontal attachment of the embodiment of FIG. 3 shown in juxtaposition to the front portion of the barrel of the embodiment of FIG. 3;
[0030] FIG. 7 is a top rear perspective view of the frontal attachment of FIG. 3;
[0031] FIG. 8 is a right side elevation view of the embodiment of FIG. 4 with the plunger cap removed and with the plunger withdrawn to an aspirated position;
[0032] FIG. 9 is a cross-sectional view taken along line 9-9 of FIG. 8;
[0033] FIG. 10 is a right side elevation view of the embodiment of FIG. 8 with the needle retracted and with the plunger fully advanced inside the barrel;
[0034] FIG. 11 is a cross-sectional view taken along line 11-11 of FIG. 10;
[0035] FIG. 12 is a front elevation view of the embodiment of FIG. 2;
[0036] FIG. 13 is a front elevation view of the embodiment of FIG. 12 with the frontal attachment repositioned relative to the barrel and with the needle retracted to the position shown in FIGS. 10 and 11;
[0037] FIG. 14 is a top front perspective view of another embodiment of a syringe of the invention, with both the needle cap and the plunger cap being shown in place as they would be when the syringe is first removed from its packaging;
[0038] FIG. 15 is the syringe embodiment as shown in FIG. 14 with the needle cap and plunger cap having been removed;
[0039] FIG. 16 is the syringe embodiment as shown in FIG. 15 with the needle safety device moved forwardly relative to the barrel and needle, and with the needle tip shield surrounding and covering the needle tip;
[0040] FIG. 17 is an exploded top perspective view of the syringe embodiment of FIG. 14;
[0041] FIG. 18 is a side elevation view of the syringe embodiment of FIG. 14;
[0042] FIG. 19 is a top plan view of the syringe embodiment of FIG. 14;
[0043] FIG. 20 is a cross-sectional view taken along line 2-2of FIG. 19;
[0044] FIG. 21 is the opposite side elevation view of the syringe embodiment as in FIG. 15 but rotated 180 around the longitudinal axis;
[0045] FIG. 22 is a side elevation view of the syringe embodiment as in FIG. 16;
[0046] FIG. 23 is a cross-sectional side elevation view taken along the longitudinal axis of the needle of the syringe embodiment as in FIG. 22; and
[0047] FIG. 24 is a bottom plan view of the syringe embodiment as in FIG. 18.
[0048] It should be noted that the drawings are not necessarily to scale.
DESCRIPTION OF PREFERRED EMBODIMENTS
[0049] Referring to FIG. 1, syringe 20 comprises barrel 22 further comprising substantially flat display surface 23, frontal attachment 24, outside wall 25 of fluid chamber 75 (visible in FIG. 9), selectively removable needle cover 26, an array of volumetric measuring indicia 27, finger flange 28, removable plunger cap 30 and locking member 40. As shown in FIG. 1, the principal volumetric measuring indicia 27 are applied to display surface 23, including for example at least the Arabic numerals identifying the number of fluid units and the associated principal measurement indicia. It should be appreciated, however, that the accompanying figures of the drawings are for illustrative purposes and are not drawn to scale and that placement of some features such as the secondary unit markings 27 relative to substantially flat display surface 23 can vary from the positions shown. At least a portion of each secondary (individual) unit indicia or markings desirably commences on display surface 23 or proximal to the edge of display surface 23, and optionally continues for a short distanced onto the curved outer wall of fluid chamber 25. Such placement is understood to be within the operational capabilities of conventional pad printing technology that is now readily available to those of ordinary skill in the art.
[0050] As depicted in FIG. 1, syringe 20 has frontal attachment 24 shown in the pre-use configuration with needle cover 26 and locking member 40 in place to prevent frontal attachment 24 from shifting laterally relative to barrel 22 prior to use because of pressure inadvertently applied to textured touch pad 46 or to the opposite side of barrel 22. Removable plunger cap 30 is also installed behind finger flange 28 to prevent the plunger (not visible) from being accidentally withdrawn from barrel 22 and to prevent inadvertent contamination inside the rear opening of barrel 22 or around the rearwardly extending handle portion of the plunger, as seen in FIG. 9, which is discussed below.
[0051] Referring to FIGS. 2, 4-5 and 12, barrel 22 and frontal attachment 24 of syringe 20 are shown in the same position as in FIG. 1 except that needle cover 26 (with locking member 40) is removed. The front opening into needle retraction cavity 92 is more clearly visible, and needle 34 is also visible, projecting forwardly from needle support member 32 of frontal attachment 24. Circumferentially spaced, axially tapered ribs 33 are disposed around needle support member 32 and provide surfaces for frictional engagement with the inside surface of needle cover 26 prior to removal. In FIG. 2, needle 34 is desirably coaxially aligned with the longitudinal axis through fluid chamber 75 (FIG. 9).
[0052] Referring to FIG. 3, needle cap 26 of syringe 20 further comprises a forwardly facing, inwardly tapered, substantially cylindrical sidewall having front end 36, rearwardly facing annular collar 38, and locking member 40 projecting rearwardly past annular collar 38. Frontal attachment 24 further comprises forwardly projecting, substantially tubular needle support member 32 with front opening 42, upper guide member 44, lower guide member 45 (visible in FIG. 7), and laterally projecting textured touch pad 46.
[0053] Syringe 20 desirably includes needle 34 with forwardly facing beveled needle tip 48, and a needle retraction mechanism further comprising coiled compression spring 50 and needle holder 52. Needle holder 52 further comprises an elongated shaft 54 with tubular bore 58 that is insertable into the rear of spring 50. The diameter of head 56 of needle holder 52 is sufficiently greater than the inside diameter of spring 50 that spring 50 can be held in compression by head 56 when frontal attachment 24 is slidably engaged with front portion 64 of barrel 22 as discussed in relation to FIGS. 6 and 7 below. The rear end of needle 34 is insertable into tubular bore 58 of needle holder 52 and attachable in fixed relation to the inside of elongated shaft 54 by any suitable, commercially available means such as an adhesive. Although a needle retraction mechanism as disclosed here is satisfactory for use in syringe 20, it will be appreciated that other similarly effective elements and mechanisms useful for rearwardly biasing needle 34 inside syringe 20 can also be used in making the invention.
[0054] Still referring to FIG. 3, annular polymeric fluid seal 60 with tubular bore 62 is desirably insertable into recess 66 in front portion 64 of barrel 22 so that the forwardly facing end of seal 60 is disposed in abutting contact with rearwardly facing head 56 of needle holder 52 when the needle retraction mechanism is installed inside frontal attachment 24 and frontal attachment 24 is attached in slidable engagement with front portion 64 of barrel 22. When frontal attachment 24 of syringe 20 is assembled to front portion 64 of barrel 22 during manufacture, a continuous, substantially linear, fluid flow path is established through needle 34, needle holder 52 and annular fluid seal 60 into tubular, longitudinally extending fluid chamber 75 (visible in FIG. 9).
[0055] In addition to front portion 64, barrel 22 further comprises substantially flat display surface 23, curved outside wall surface 25, finger flange 28 and rearwardly projecting annular collar 70. During assembly of syringe 20, elastomeric plunger seal 76 is desirably installed on forwardly projecting boss 74 on the front end of plunger handle 72 opposite rearwardly facing plunger thumb pad 78, and plunger handle 72 is then inserted into a rearwardly facing opening defined by annular collar 70. Assembly of syringe 20 is then completed by installing substantially cylindrical plunger cap 30 on the rearwardly facing end of barrel 22. Plunger cap 30 further comprises open front end 80, cylindrical bore 82 and closed rear end 84. Plunger cap 30 is installed around plunger thumb pad 78 and in frictional engagement with the outside wall of annular collar 70. Volumetric measuring indicia 27 applied as discussed in relation to FIG. 1 also appear on the outwardly facing portions of substantially flat display surface 23 and curved outside wall surface 25.
[0056] FIGS. 3, 6 and 11 further disclose the forwardly facing opening into needle retraction cavity 92 in relation to front portion 64 of barrel 22. Needle retraction cavity 92 has a closed rear end that is adjacent to finger flange 28, and is bounded by side walls 90, 95, bottom wall 94, and a top wall that also includes upwardly facing, substantially flat display surface 23 of barrel 22.
[0057] The assembly of frontal attachment 24 to front portion 64 of barrel 22 of syringe 20 is further described and explained in relation to FIGS. 6 and 7. Referring to FIG. 6, annular fluid seal 60 (visible in FIG. 3) is first inserted into recess 66 of front portion 64 of barrel 22. Front portion 64 further comprises laterally extending top rail 68 and bottom rail 69 that are disposed in transverse relation to the longitudinal axis through fluid chamber 75 (FIG. 9) of barrel 22. Rounded attachment guides 96, 98 are disposed forwardly of top and bottom rails 68, 69, respectively, and are configured to facilitate the assembly of frontal attachment 24 to front portion 64 of barrel 22 by passing above and below the arm connecting textured touch pad 46 to the back side of frontal attachment 24.
[0058] Referring to FIG. 7, annular opening 112 is provided in the back side of frontal attachment 24 to facilitate insertion of spring 50 and needle holder 52, discussed above in relation to FIG. 3, and spring 50 is desirably compressed between an annular shoulder inside front opening 42 (visible in FIG. 11) and is held in compression behind head 56 of needle holder 52 while frontal attachment 24 is moved into sliding engagement with front portion 64 of barrel 22. Frontal attachment 24 further comprises upper guide 44 having a downwardly facing, laterally extending recess 100 and lower guide 45 having an upwardly facing, laterally extending recess 102. Upper ramp and lower ramp 104, 106, respectively, of frontal attachment 24 are configured to slide over two laterally spaced-apart sets of opposed ramps with blocking shoulders 77, 79 (the lower set not being visible in FIG. 6). Laterally extending top rail 68 and bottom rail 69 of front portion 64 of barrel 22 are desirably cooperatively engaged with upper and lower recesses 100, 102, respectively, by sliding frontal attachment 24 onto front portion 64 of barrel 22 when frontal attachment 24 and front portion 64 are positioned as shown in FIG. 6. As pressure is applied to textured touch surface 46, frontal attachment 24 moves along rails 68, 69 until top and bottom blocking shoulders 108 of upper guide 44 pass over and then drops into facing relation to upper and lower blocking shoulders 77. At this time, needle support member 32 and needle holder 52 (not shown in FIGS. 6 and 7) are desirably coaxially aligned with the longitudinal axis of fluid chamber 75 (visible in FIG. 9). Any attempt to move frontal attachment 24 back to a disconnected position as shown in FIG. 6 will be resisted by facing and abutting contact between upper and lower blocking shoulders 77 of front portion 64 and top and bottom blocking shoulders 108, 110, respectively, of frontal attachment 24.
[0059] FIGS. 4 and 5 depict syringe 20 of FIG. 2 with the needle cover removed and with plunger cap 30 still in place and with textured touch surface 46 in the initial position relative to barrel 22 as described above. Needle 34 is installed inside bore 58 of needle holder 52, which is seated inside needle support member 32 of frontal attachment 24, with spring 50 compressed between head 56 (FIG. 3) of needle holder 52. Spring 50 applies a rearwardly directed biasing force to needle holder 52 and needle 34, and is pressed by spring 50 into facing and abutting contact with the front surface of annular fluid seal 60, thereby establishing a coaxially aligned fluid path through needle 34, needle holder 52 and fluid seal 60 into fluid chamber 75 (visible in FIG. 9) of barrel 22. As shown in FIGS. 4 and 5, plunger seal 76 is pushed fully forward into substantially cylindrical fluid chamber 75 of barrel 22.
[0060] Referring to FIGS. 8-9, syringe 20 is configured so that fluid can be aspirated into the syringe, with textured touch pad 46 again in the same initial position as previously described. Plunger cap 30 (as seen in FIGS. 2, 4-5) is removed and plunger handle 72 is withdrawn as it would be while aspirating fluid into fluid chamber 75. In FIG. 9 it is seen that needle retraction cavity 92 is substantially coextensive in length with fluid chamber 75, thereby facilitating the placement of volumetric measuring indicia 27 on substantially flat surface 23 (visible in FIG. 3) that facilitates full utilization of the volume of fluid chamber 75 and also facilitating the retraction of needles such as biopsy needles that are often substantially longer than needle 34 (visible inside needle retraction cavity 92 in FIG. 11 below). Once fluid is aspirated into fluid chamber 75, fluid can also be injected into a patient or expelled from fluid chamber 75 by pressing forwardly on plunger thumb pad 78 while applying finger pressure against the forwardly facing side of flange 28.
[0061] Referring to FIGS. 10-11 and 13, plunger handle 72 and plunger seal 76 have been pushed forwardly to empty fluid chamber 75. To initiate needle retraction, pressure is applied to textured touch pad 46, which moves frontal attachment to a position where needle support member 32 is aligned with needle retraction cavity 92. Because needle retraction chamber 92 has a front opening that is larger than head 56 of repositioned needle holder 52, the biasing force of compressed spring 52 pushes needle holder 52 rearwardly and causes needle holder 52 and needle 34 to be propelled into the distal end of needle retraction cavity 92.
[0062] Referring again to FIGS. 6 and 7, the further application of force to textured touch surface 46 of frontal attachment 24 relative to barrel 22 as described above in relation to FIGS. 10-11 produces sliding relative movement between frontal attachment 24 and front portion 64 of barrel 22. This movement causes upper ramp 104 and lower ramp 106 to slide over the second set of opposed ramps and blocking shoulders 79 so that top and bottom blocking shoulders 108, 110 are placed in facing and abutting contact with upper and lower blocking shoulders 79, thereby preventing frontal attachment 24 from being returned to the use position relative to barrel 22.
[0063] Referring to FIGS. 14-24 generally, and specifically to FIGS. 14-17, another embodiment of the invention is disclosed comprising syringe 200 further comprising barrel 210, needle safety device 212, needle cap 214 and plunger cap 216. Barrel 210 desirably comprises at least one longitudinally extending, substantially flat indicia display surface 220 marked with an easily readable volumetric scale. In one preferred embodiment of the invention, barrel 210 comprises two oppositely facing, substantially flat indicia display surfaces 220, 236 (FIG. 16). Following removal of needle cap 214 and plunger cap 216 (FIG. 14) from the device, forwardly projecting needle 225 and rearwardly projecting plunger 224 (FIG. 15) become visible. Needle 225 is coaxially aligned with plunger 224 and is held in fixed relation to a narrow bore 250 inside nose 234 (FIGS. 16, 17, 20) at the front end of barrel 210. (Alternatively, it will be appreciated that needle 225 and nose 234 can be cooperatively configured so that needle 225 is releasably attachable to nose 234 if desired to permit the use of differently sized needles with barrel 234.)
[0064] Bore 250 places needle 225 in fluid communication with a fluid reservoir disposed inside tubular barrel 258 between nose 234 and plunger seal 260 on the front end of plunger handle 240. When plunger handle 240 is pushed fully forward against the rear of nose 234 of barrel 210 prior to an injection (FIG. 20) or following an injection (FIG. 23) the fluid chamber is not visible. When syringe 200 is prepared for an injection, as discussed below, the fluid reservoir is the space (not visible in these views) inside tubular section 258 that is between the rear of nose 234 and the front of plunger seal 260 as fluid is drawn into syringe 200.
[0065] Referring to FIG. 17, needle safety device 212 also comprises activation handle 228 and needle tip shield 232. Activation handle 228 further comprises rear end 268, touch pad 226 and a pair of longitudinally extending channels 227 disposed on opposite sides of activation handle 228. The function of channels 227 is discussed below in relation to sliding engagement with barrel 210. Needle tip shield 232 further comprises inside bore 248 that is coaxially aligned with needle 225 and with nose 234 of barrel 210. Needle tip shield 232 desirably has an inside diameter that will allow needle tip shield 232 to slide over and surround coaxially aligned nose 234 when in the position shown in FIGS. 15, 21 and needle tip shield 232 is sufficiently long to safely cover the tip end of needle 225 when moved forwardly as in FIGS. 16, 22-23. Slight frictional engagement can be provided between the inside wall of needle tip shield 232 and nose 234 to help hold needle safety device 212 in a stable axial position relative to barrel 210 during use of syringe 200. Needle safety device 212 is desirably unitarily molded from a polymeric material and is cooperatively sized and configured to slidably engage barrel 210, also taking into consideration the range of needle lengths intended for use with syringe 200.
[0066] Referring again to FIG. 17, barrel 210 further comprises coaxially aligned nose 234 with internal bore 250 and tubular section 258 extending rearwardly from nose 234 to fingertip flange 218. The rear end of tubular section 258 is open and communicates with the inside of cylindrical, rearwardly extending collar 230 to which plunger cap 216 is releasably attachable. Opposed indicia display surfaces 220, 236 (FIG. 16) are desirably parallel, longitudinally extending, substantially flat, printable surfaces each having an oppositely facing volumetric scale comprising appropriate indicia located adjacent to tubular section 258 to facilitate easy reading of a liquid level inside tubular section 258 by a user. A longitudinally extending rail 256 with an inwardly projecting retainer edge 254 is desirably provided on the inwardly facing walls of each of the outwardly facing indicia display surfaces 220, 236. Longitudinally extending rails 256 are cooperatively sized and configured to engage and provide a smooth, slidable interface along each of aligned channels 227 of needle safety device 212. Barrel 210 is desirably molded from a medical grade polymeric material and is sufficiently transparent to permit the liquid level drawn into tubular section 258 of syringe 200 to be plainly viewed by a user. Still referring to FIG. 17, plunger 224 further comprises thumb cap 238, plunger handle 240, plunger seal retainer body 266 and annular recess 264.
[0067] The cooperatively configured structural elements and operation of needle safety device 212 relative to barrel 210 of syringe 200 are further described and explained in relation to FIGS. 15-17, 20, 22-23. During assembly of syringe 200, activation handle 228 of needle safety device 212 is aligned with and inserted over tubular section 258 of barrel 210 with rails 256 engaging channels 227. Needle safety device 212 is moved rearwardly relative to barrel 210 until needle tip shield 232 surrounds nose 234 of barrel 210 and rear end 268 of needle safety device 212 frictionally engages oppositely disposed rear stops 246. Slide stops 242 each having a ramp 244 and stop shoulder 252 are provided rearwardly of rails 256 and forwardly of rear stops 246. Opposed and facing ramps 244 allow activation handle 228 to slide forwardly relative to barrel 210 to a point where needle tip shield 232 covers and protects the tip end of needle 225 following use of syringe 210. After the tip end of needle 225 is covered, opposed and facing stop shoulders 252 prevent activation handle 228 from being moved rearwardly relative to barrel 210 to again expose the needle tip.
[0068] When needle safety device 212 and needle tip shield 232 are disposed in the position shown in FIGS. 15, 20-21 (referred to as the first stop position) relative to barrel 210 and needle 225, needle tip shield 232 surrounds nose 234 of barrel and a portion of needle 225. When needle safety device 212 of syringe 200 is in the first stop position, the front tip of needle 225 can be inserted through the stopper of a medicine vial (e.g., an insulin bottle) and medicine can be drawn into a fluid reservoir disposed inside tubular section 258 (FIGS. 17, 20) of barrel 210 by pulling rearwardly on plunger 224 that slidably engages the inside wall of tubular section 258.
[0069] Following an injection or other use of syringe 200, syringe 200 can be reconfigured into a safe position with the needle tip covered and protected from inadvertent contact with a health care professional or patient by selectively moving needle safety device 212 forwardly to the position shown in FIGS. 16, 22-23, which is the second stop position. When syringe 200 is configured with needle safety device 212 in the second stop position, the front tip of needle 225 is circumferentially surrounded by needle tip shield 232 and (as shown in FIGS. 16, 23) the front end of needle tip shield 232 extends sufficiently forward of the tip end of needle 225 that an individual will not receive an unintended needle stick if the front end of syringe 200 is pressed against his or her skin.
[0070] It will become apparent to those of ordinary skill in the art upon reading this specification in relation to the accompanying drawings that various other modifications and alterations can also be made to the embodiments disclosed here, and it is intended that the scope of the invention be limited only by the broadest interpretation of the appended claims to which the inventors are legally entitled.
